Cleared Traditional

K971914 - TECA NCS ELECTRODE SYSTEM 2000

K971914 is an FDA 510(k) clearance for TECA NCS ELECTRODE SYSTEM 2000, manufactured by Medelec, Inc. D.B.A. Teca Corp.. The device is a Class 2 Neurology device with product code GXY cleared through the Traditional 510(k) pathway after a 307-day FDA review.

K971914 · Medelec, Inc. D.B.A. Teca Corp. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1998
Decision
307d
Days
Class 2
Risk

K971914 is an FDA 510(k) clearance for the TECA NCS ELECTRODE SYSTEM 2000. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Medelec, Inc. D.B.A. Teca Corp. (Pleasantville, US). The FDA issued a Cleared decision on March 26, 1998 after a review of 307 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Medelec, Inc. D.B.A. Teca Corp. devices

FDA 510(k) Submission Details - K971914

510(k) Number K971914 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 23, 1997
Decision Date March 26, 1998
Days to Decision 307 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
159d slower than avg
Panel avg: 148d · This submission: 307d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 242
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K971914.
EEG ELECTRODES MODEL 445 SERIES
K982053 · Class A Ent. · Apr 1999
EVERLAST NEUROSTIMULATION ELECTRODES 2X 2,MODEL # EL2020
K983741 · Axelgaard Mfg. Co., Ltd. · Dec 1998
SLE ELECTRODES AND ACCESSORIES
K980410 · Specialized Laboratory Equipment, Ltd. · Oct 1998
MSB TENS ELECTRODES (DISPOSABLE)
K980229 · Msb , Ltd. · Feb 1998
DREAM CATCHER
K972122 · Rest Technologies, Inc. · Aug 1997
NEUROLINE, DISPOSABLE REFERENCE AND RECORDING ELECTRODES TYPE NO: 72000-S, 72010-K
K970639 · Medicotest, Inc. · May 1997